Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

'Right Now, You've Still Got To Avoid The Stock,' Jim Cramer Says About This Aerospace Company

Published 30/09/2022, 15:10
Updated 30/09/2022, 16:11
© Reuters.  'Right Now, You've Still Got To Avoid The Stock,' Jim Cramer Says About This Aerospace Company

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Sherwin-Williams Co (NYSE: NYSE:SHW) might go lower as the PE (price-to-earnings) multiple is still "way too high" on the stock.

When asked about Charles River Laboratories International, Inc. (NYSE: CRL), Cramer said, "It finally doesn’t have a high price-to-earnings multiple. I would actually start buying that stock right here, right now."

The "Mad Money" host recommended not touching Alibaba (NYSE:BABA) Group Holding Ltd - ADR (NYSE: BABA).

Cramer said Cassava Sciences Inc (NASDAQ: SAVA) is the "kind of company that could strike gold or not, but you’ve got to understand you could lose everything."

When asked about Boeing Co (NYSE: NYSE:BA), he said, "Right now, you’ve still got to avoid the stock."

Cramer said it’s okay to buy Revance Therapeutics Inc (NASDAQ: RVNC) as the stock is "good in this environment."

When asked about Seagen Inc (NASDAQ: SGEN), Cramer said, "I think Merck & Co., Inc. (NYSE: MRK) has to buy it. I would not sell this stock here, I’d be a buyer."

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.